The Killing Antidote

MetalStar Studio · 2024 · $29.99 · Action · deal grade C

• Estimated net residual revenue: $27.8k to $41.8k per month
• Opportunity: $34.8k per month at x1.00 dormancy
• Estimated lifetime owners: 236.8k
• 89%% positive across 7722 reviews · 158.8 reviews/month

Why it's flagged

• Developer active, last post 5 months ago
• Last build shipped 4 months ago

This case as Markdown · Estimates carry ±30-50%% error per title.